Article

Estrogen receptor beta activation prevents glucocorticoid receptor-dependent effects of the central nucleus of the amygdala on behavior and neuroendocrine function.

Department of Biomedical Sciences, Neuroscience Division, Colorado State University, Fort Collins, CO, USA.
Brain research (Impact Factor: 2.83). 04/2010; 1336:78-88. DOI: 10.1016/j.brainres.2010.03.098
Source: PubMed

ABSTRACT Neuropsychiatric disorders such as anxiety and depression have formidable economic and societal impacts. A dysregulation of the hypothalamo-pituitary-adrenal (HPA) axis leading to elevated endogenous glucocorticoid levels is often associated with such disorders. Chronically high glucocorticoid levels may act upon the central nucleus of the amygdala (CeA) to alter normally adaptive responses into those that are maladaptive and detrimental. In addition to glucocorticoids, other steroid hormones such as estradiol and androgens can also modify hormonal and behavioral responses to threatening stimuli. In particular, estrogen receptor beta (ERbeta) agonists have been shown to be anxiolytic. Consequently, these experiments addressed the hypothesis that the selective stimulation of glucocorticoid receptor (GR) in the CeA would increase anxiety-like behaviors and HPA axis reactivity to stress, and further, that an ERbeta agonist could modulate these effects. Young adult female Sprague-Dawley rats were ovariectomized and bilaterally implanted via stereotaxic surgery with a wax pellet containing the selective GR agonist RU28362 or a blank pellet, to a region just dorsal to the CeA. Four days later, animals were administered the ERbeta agonist S-DPN or vehicle (with four daily sc injections). Anxiety-type behaviors were measured using the elevated plus maze (EPM). Central RU28362 implants caused significantly higher anxiety-type behaviors in the EPM and greater plasma CORT levels than controls given a blank central implant. Moreover, S-DPN treated animals, regardless of type of central implant, displayed significantly lower anxiety-type behaviors and post-EPM plasma CORT levels than vehicle treated controls or vehicle treated animals implanted with RU28362. These results indicate that selective activation of GR within the CeA is anxiogenic, and peripheral administration of an ERbeta agonist can overcome this effect. These data suggest that estradiol signaling via ERbeta prevents glucocorticoid-dependent effects of the CeA on behavior and neuroendocrine function.

0 Bookmarks
 · 
63 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Real life by definition combines heritability (e.g., the legacy of exposures) and experience (e.g. stress during sensitive or ‘critical’ periods), but how to study or even model this interaction has proven difficult. The hoary concept of evaluating traits according to nature versus nurture continues to persist despite repeated demonstrations that it retards, rather than advances, our understanding of biological processes. Behavioral genetics has proven the obvious, that genes influence behavior and, vice versa, that behavior influences genes. The concept of Genes × Environment (G × E) and its modern variants was viewed as an improvement on nature-nurture but has proven that, except in rare instances, it is not possible to fractionate phenotypes into these constituent elements. The entanglement inherent in terms such as nature-nurture or G × E is a Gordian knot that cannot be dissected or even split. Given that the world today is not what it was less than a century ago, yet the arbitrator (differential survival and reproduction) has stayed constant, de novo principles and practices are needed to better predict what the future holds. Put simply, the transformation that is now occurring within and between individuals as a product of global endocrine disruption is quite independent of what has been regarded as evolution by selection. This new perspective should focus on how epigenetic modifications might revise approaches to understand how the phenotype and, in particular its components, is shaped. In this review we summarize the literature in this developing area, focusing on our research on the fungicide vinclozolin.
    Molecular and Cellular Endocrinology 12/2014; 398(1-2). DOI:10.1016/j.mce.2014.07.013 · 4.24 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Huntington's disease (HD) is an autosomal dominant, neurodegenerative disease caused by a CAG tandem repeat mutation encoding a polyglutamine tract expansion in the huntingtin protein. Depression is among the most common affective symptoms in HD but the pathophysiology is unclear. We have previously discovered sexually dimorphic depressive-like behaviours in the R6/1 transgenic mouse model of HD at a pre-motor symptomatic age. Interestingly, only female R6/1 mice display this phenotype. Sexual dimorphism has not been explored in the human HD population despite the well-established knowledge that the clinical depression rate in females is almost twice that of males. Female susceptibility suggests a role of sex hormones, which have been shown to modulate stress response. There is evidence suggesting the gonads are adversely affected in HD patients, which could alter sex hormone levels. The present study examined the role sex hormones play on stress response in the R6/1 mouse model of HD, in particular, its modulatory effect on the hypothalamic-pituitary-adrenal (HPA) axis and depression-like behaviour. We found that the gonads of female R6/1 mice show atrophy at an early age. Expression levels of gonadotropin-releasing hormone (GnRH) were decreased in the hypothalamus of female HD mice, relative to wild-type female littermates, as were serum testosterone levels. Female serum estradiol levels were not significantly changed. Gonadectomy surgery reduced HPA-axis activity in female mice but had no effect on behavioural phenotypes. Furthermore, expression of the estrogen receptor (ER) α gene was found to be higher in the adrenal cells of female HD mice. Finally, administration of an ERβ agonist diarylpropionitrile (DPN) rescued depressive-like behaviour in the female HD mice. Our findings provide new insight into the pathogenesis of sexually dimorphic neuroendocrine, physiological and behavioural endophenotypes in HD, and suggest a new avenue for therapeutic intervention.
    Experimental Neurology 09/2014; 263. DOI:10.1016/j.expneurol.2014.09.009 · 4.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sex differences in the activity of the hypo-thalamus-pituitary-adrenal (HPA) axis in rats are programmed by neonatal estrogens; expo-sure of female neonates to estradiol (E 2) leads to overt defeminization of endocrine and behavioral functions in adulthood. E 2 activates both estrogen receptor isoforms (ERα and ERβ); these are widely expressed in the brain, and differentially regulate HPA axis activity in adulthood. However, the contributions of each ER isoform to the sex-specific organization of the neural mechanisms governing HPA axis function remain unknown. ERα, ERβ agonists (PPT and DPN, respectively) or E 2 were admin-istered to female rats on days 1-10 of life. Animals subsequently underwent endocrine (HPA axis and reproductive) and behavioral profiling (anxiety-related and reproductive) in adulthood, and patterns of expression of rele-vant genes were monitored in limbic struc-tures post mortem. Exposure of neonatal females to PPT or DPN led to distinctly differ-ent HPA secretory profiles, neither of which completely recapitulated the effects of E 2 . Thus, whereas impaired glucocorticoid nega-tive feedback was the most prominent effect of PPT treatment, increased basal corticosterone secretion was the most obvious characteristic of DPN-treated animals. Behavioral analysis revealed higher anxiety levels in PPT-treated animals, similar to those observed in E 2 -treat-ed female neonates and control males; in con-trast, DPN treatment was associated with reduced anxiety-like behavior. Parallel treat-ment-specific alterations in the expression of the genes encoding mineralocorticoid (MR) and glucocorticoid (GR) receptors in the hip-pocampus and amygdala and altered expres-sion of ERβ mRNA in discrete brain regions, as well as disturbed ovarian activity, were also found; together, they suggest potential mecha-nisms that could account for the different endocrine and behavioral phenotypes observed. Defeminization of HPA axis activity and associated anxiety-related behavior depends on balanced activation of ERα and ERβ during early postnatal life, rather than on the activa-tion of a specific ER isoform. Long-term E 2 -, PPT-and DPN-induced alterations in the expression levels of GR and MR in the hip-pocampus and amygdala, as well as disrupted ovarian activity appear to be largely responsi-ble for eliciting and maintaining the aberrant endocrine and behavioral phenotypes induced by estrogenization of neonatal females.
    10/2011; 1(2). DOI:10.4081/es.2011.e12

Preview

Download
0 Downloads
Available from